s6y
Company name or ticker
Search
Firestone Karen
3
Amylyx Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Filed
Monday, March 20, 2023
Period
Mar 16, 2023
Accession number
0000899243-23-009164
Documents
FORM 3 SUBMISSION
3
EX-24 DOCUMENT
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header